Impact Partnership Wealth’s AbbVie ABBV Stock Holding History

Impact Partnership Wealth’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$735K	Sell	2,811 -2,701	-49%	-$692K	0.06%	208
2026 Q2	$1.39M	Buy	5,512 +3,872	+236%	+$833K	0.13%	107
2026 Q1	$357K	Buy	1,640 +41	+3%	+$9.1K	0.04%	248
2025 Q4	$365K	Buy	1,599 +546	+52%	+$124K	0.05%	250
2025 Q3	$244K	Sell	1,053 -2,556	-71%	-$520K	0.04%	257
2025 Q2	$670K	Buy	+3,609	New	+$671K	0.12%	96
2025 Q1	–	Sell	-4,842	Closed	-$860K	–	260
2024 Q4	$860K	Sell	4,842 -754	-13%	-$139K	0.17%	66
2024 Q3	$1.11M	Sell	5,596 -72	-1%	-$13.4K	0.25%	45
2024 Q2	$972K	Buy	5,668 +4,982	+726%	+$825K	0.26%	49
2024 Q1	$125K	Sell	686 -5,126	-88%	-$883K	0.05%	229
2023 Q4	$901K	Buy	5,812 +1,365	+31%	+$199K	0.33%	35
2023 Q3	$663K	Buy	4,447 +301	+7%	+$44.2K	0.21%	52
2023 Q2	$559K	Buy	+4,146	New	+$608K	0.19%	61

Other funds holding ABBV

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return

Impact Partnership Wealth's ABBV Position: Q3 2026 in Review

Impact Partnership Wealth reduced its AbbVie (ABBV) stake by 49% in Q3 2026, selling an estimated $692K and leaving 2,811 shares worth $735K. The position accounts for 0.06% of the portfolio, ranked #208.

Impact Partnership Wealth first reported a position in ABBV in Q2 2023 and has held it in 13 quarters since. The position peaked at $1.39M in Q2 2026. 2,874 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

Impact Partnership Wealth held 2,811 shares of AbbVie worth $735K as of Q3 2026.
Impact Partnership Wealth sold 2,701 AbbVie shares in Q3 2026, an estimated $692K.
AbbVie made up 0.06% of Impact Partnership Wealth's portfolio in Q3 2026, its #208 holding.
Impact Partnership Wealth first reported a position in AbbVie in Q2 2023 and has held it in 13 quarters since.
Impact Partnership Wealth's AbbVie position peaked at $1.39M in Q2 2026.
2,874 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Impact Partnership Wealth's 13F filing for Q3 2026, filed 9 Nov 2026.